Nektar Therapeutics
Clinical trials sponsored by Nektar Therapeutics, explained in plain language.
-
New injection tested to regrow hair in severe alopecia
Disease control OngoingThis study is testing whether an investigational drug called rezpegaldesleukin, given as an injection, can help regrow hair in adults with severe to very severe alopecia areata. About 94 participants will be randomly assigned to receive either the drug or a placebo (an inactive s…
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New injection shows promise for controlling severe eczema
Disease control OngoingThis study is testing whether an investigational drug called rezpegaldesleukin can help control moderate-to-severe eczema (atopic dermatitis) in adults. About 400 participants will receive either the drug or a placebo injection to compare effectiveness. The main goal is to see ho…
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC